Skip to content
Search

Latest Stories

National Services Scotland announces closure of free PPE delivery from March 2024

National Services Scotland announces closure of free PPE delivery from March 2024

Community pharmacy contractors will not be able to order PPE from PECOS online ordering portal, but their account will not be suspended

NHS National Services Scotland (NSS) has informed dental, optometric and community pharmacy contractors in the country that the “at no costs” Personal Protective Equipment (PPE) which has been made available to them from NHS National Procurement will stop at the end of this financial year.


Paul Cushley, Chair of the National Primary Care PPE Group, has sent a letter to the contractors, stating that the last deliveries of the PPE will be made in March 2024, for items ordered through the PECOS online ordering portal by end of February 2024.

However, the contractors’ PECOS account will not be suspended to provide future opportunities for ordering between contractors and Boards, he said.

The contractors are also informed that any over ordering, above the volume of PPE agreed between them and their Health Board, will lead to immediate termination of both the delivery and their PECOS account.

Paul has asked the contractors to now engage with their commercial supplier of PPE and sundries to discuss their ongoing requirements.

NHS National Procurement, who had previously only supplied PPE to the secondary care sector, extended the service to primary care sector following the COVID-19 pandemic, which led to worldwide increase in demand for PPE.

Later, National Procurement moved from delivering extra PPE to Health Board central stores to a direct “to the door delivery service” to every contractor in every Health Board in Scotland.

NHS reminded the contractors that the removal of access to at no cost PPE is “not a reflection of any significant change in the National Infection Prevention and Control Manual.”

They can continue to use the link to access the most up to date version of this guidance regarding their requirements.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less